Randomized trial · people

Ecnoglutide: HbA1c fell up to 2.39% at 20 weeks in type 2 diabetes

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In a placebo-controlled trial in people with type 2 diabetes, ecnoglutide lowered blood sugar at every dose tested over 20 weeks, and the largest drop came in the highest dose arm.

Kind
Randomized trial
Studied in
People
Number studied
145
Published
2024
Journal
Nat Commun

What they tested

Does a once-weekly ecnoglutide shot lower HbA1c, a long-term average of blood sugar, in adults with type 2 diabetes after 20 weeks?

How the study was done

A randomized, double-blind, placebo-controlled phase 2 trial run at multiple centers in 145 adults with type 2 diabetes. Each person got 0.4, 0.8 or 1.2 mg of ecnoglutide or a placebo (a dummy shot) once a week for 20 weeks.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking ecnoglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

By the end of treatment, HbA1c had dropped by 1.81% in the 0.4 mg arm, 1.90% in the 0.8 mg arm and 2.39% in the 1.2 mg arm, compared with 0.55% on placebo (P < 0.0001). In the 1.2 mg arm, 71.9% reached an HbA1c of 6.5% or lower, against 9.1% on placebo. In that same arm, 33.3% lost at least 5% of their body weight, against 3.0% on placebo. The researchers judged the drug safe and tolerable overall.

What it doesn’t show

With 145 people followed for 20 weeks, the trial is too small and too brief to judge lasting benefits or uncommon harms. Ecnoglutide was tested against placebo only, not against other diabetes or GLP-1 medicines.

The paper

Zhu et al. Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial. Nat Commun. 2024.

The compound

More studies on Ecnoglutide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking ecnoglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo